sábado, 12 de septiembre de 2020

Have you seen the latest news and insights on Cystic Fibrosis News Today?


Cystic Fibrosis Weekly Update

Contents:

How to Keep Your Growth Game Strong

Sep 11, 2020 09:00 am | Lara Govendo



growthSeptember is Self-improvement Month. It’s a timely reminder to stay woke on my growth game. Stagnation is not an option for me. It often leads to complacency, which then leads to murdered dreams. With my new lease on life, I do not have the luxury of staying the same. Personal growth became a part of […]
The post How to Keep Your Growth Game Strong appeared first on Cystic Fibrosis News Today.
Read More
share on TwitterLike How to Keep Your Growth Game Strong on Facebook

Activities Underway for Newborn Screening Awareness Month

Sep 11, 2020 07:00 am | Mary Chapman



As it does each September during Newborn Screening Awareness Month, Baby’s First Test is sharing information and stories that highlight efforts throughout the U.S. to bring attention to newborn testing. Baby’s First Test is a program of Expecting Health, an organization focused on pregnancy and newborn health. The program offers newborn screening (NBS) resources to help guide parents, […]
The post Activities Underway for Newborn Screening Awareness Month appeared first on Cystic Fibrosis News Today.
Read More
share on TwitterLike Activities Underway for Newborn Screening Awareness Month on Facebook

Aridis, FDA Agree to Simplify AR-501 Trial Design Based on Positive Safety Data

Sep 10, 2020 07:00 am | Forest Ray



AR-501, FDA agreementThe U.S. Food and Drug Administration (FDA) has agreed to simplify Aridis Pharmaceuticals‘ planned Phase 2 trial of AR-501, an investigational inhaled treatment for chronic lung infections in patients with cystic fibrosis (CF). The decision was based on positive safety data from a Phase 1 trial in healthy adults. “The change to an adaptive style clinical trial […]
The post Aridis, FDA Agree to Simplify AR-501 Trial Design Based on Positive Safety Data appeared first on Cystic Fibrosis News Today.
Read More
share on TwitterLike Aridis, FDA Agree to Simplify AR-501 Trial Design Based on Positive Safety Data on Facebook

Recent News

Savara Closing Trial of Molgradex in Treating NTM Lung Infections in CF Patients
Listening to Both Sides of the Mask Debate
$10M Grants Will Fund New Research Seeking to Improve Transplant Outcomes
CF Patients With Poorer Lung Function at Greater Risk of Premature or Smaller Baby, Study Shows
New Technology Could Improve Detection of Biomarkers for CF, Other Diseases

No hay comentarios:

Publicar un comentario